2023-07-06 04:15:37 ET
- Nymox Pharmaceutical ( NASDAQ: NYMX ) informed shareholders on Wednesday that it has received a delisting determination letter from Nasdaq on failing to regain with the minimum bid price requirement.
- The deadline to regain compliance with Nasdaq listing requirements was July 3, 2023.
- The company's shares will be suspended from trading on Nasdaq at the open of business on July 7, 2023.
- The company said its common stock will be quoted on the OTC Markets after delisting from Nasdaq.
- Shares of NYMX are down 14.3% in premarket trade on Thursday.
For further details see:
Nymox Pharmaceutical receives potential delisting notice from Nasdaq